Specifically, Black women had a 41% higher relative risk of coronary heart disease and a 16% rate of premature menopause, ...
Opioids such as morphine, oxycodone and fentanyl provide pain relief by binding to mu-opioid receptors, which are specialized ...
A new report found that despite widespread AI adoption in U.S. health systems, many patients still struggle to access care ...
Financial performance strengthened with 2025 revenue rising to $16.0 billion and operating margin improving to 2.8%, ...
Doctors Without Borders has accused Gilead of restricting access to its HIV prevention drug lenacapavir by refusing humanitarian sales and limiting supply, arguing this is hindering global efforts to ...
A long-term extension trial of 389 patients found Attruby significantly cut death risk in transthyretin amyloid ...
Marta J. Van Beek, M.D., M.P.H., sees problems when she looks with the Merit-based Incentive Payment System (MIPS). “The ...
The FDA has approved Eli Lilly's oral GLP-1, Foundayo. Let the heated rivalry with oral Wegovy begin
Eli Lilly announced this morning that the FDA has, as was expected, approved its oral GLP-1, orforglipron, as treatment for ...
Alkermes announced today the initiation of the Brilliance Studies, a phase 3 program that will test the safety and efficacy of alixorexton compared with placebo in adults, according to a news release.
A compound isolated from an edible mushroom may hold the potential as an anti-cancer agent against melanoma, according to a ...
A new preclinical study found that inhibiting the enzyme LSD1 can activate the skin’s immune system and suppress tumor growth ...
Pulmonary fibrosis is a progressive interstitial lung disease characterized by excessive extracellular matrix deposition, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results